While computational validation remains the primary endpoint (35.7% of projects), there is an increasing trend toward higher-level evidence.
← all excerpts
Automated Processes and Artificial Intelligence in Generating Candidates for Oncology Drug Repurposing: Three-Year Scoping Review of Data.
1
—
—